These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3279628)

  • 1. The intake of initially high doses of cyclosporine A in cadaveric kidney transplantation is not justified. Results of a prospective study.
    Niebel W; Albrecht KH; Metz K; Jakubowski HD; Windeck R; Eigler FW
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):394-7. PubMed ID: 3279628
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 3. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
    Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation.
    Slapak M; Geoghegan T; Digard N; Ahmed K; Sharman VL; Crockett R
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):41-5. PubMed ID: 3551255
    [No Abstract]   [Full Text] [Related]  

  • 5. Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantation.
    Fries D; Hiesse C; Santelli G; Gardin JP; Cantarovich M; Lantz O; Charpentier B; Paillard M; Benoit G
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):130-5. PubMed ID: 3291226
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose cyclosporine, anti-lymphocyte globulin, and steroids in first cadaveric renal transplantation.
    Griño JM; Alsina J; Castelao AM; Sabate I; Mestre M; Gil-Vernet S; Andrés E; Sabater R
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):18-20. PubMed ID: 3051579
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term results of cyclosporine in cadaveric renal transplantation from a single center.
    Jain AB; Buckels JA; Adu D; Michael J; Mackintosh P; McMaster P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):82-5. PubMed ID: 3291320
    [No Abstract]   [Full Text] [Related]  

  • 8. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
    Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients.
    Berg KJ; Nordby G; Rootwelt K; Djøseland O; Fauchald P; Mehl A; Narverud J; Talseth T
    Transplant Proc; 1988 Jun; 20(3):413-5. PubMed ID: 3289171
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cyclosporin A in cadaveric kidney transplantation. A randomized study].
    Griñó JM; Seron D; Castelao AM; Sabaté I; Gil-Vernet S; Andrés E; Sabater R; Franco E; Torras J; Alsina J
    Med Clin (Barc); 1988 May; 90(18):719-23. PubMed ID: 3050303
    [No Abstract]   [Full Text] [Related]  

  • 11. Is withdrawal of steroids hazardous to cadaveric renal transplants under treatment with cyclosporine?
    Hillebrand G; Krumme D; Schleibner S; Land W; Gurland HJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):126-9. PubMed ID: 3291225
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of low doses of cyclosporine A plus azathioprine.
    Andreu J; Ricart MJ; Oppenheimer F; Vilardell J; Sans A
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):28-9. PubMed ID: 3051583
    [No Abstract]   [Full Text] [Related]  

  • 13. Preservation effect on oligo-anuria in the cyclosporine era: a prospective trial with 26 paired cadaveric renal allografts.
    Mendez R; Mendez RG; Koussa N; Cats S; Bogaard TP; Khetan U
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2047-50. PubMed ID: 3547908
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of cyclosporine on the early postoperative function of allografted kidneys with warm ischemic damage.
    Ohshima S; Fujita T; Asano H; Ono Y
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2081-4. PubMed ID: 3547911
    [No Abstract]   [Full Text] [Related]  

  • 15. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 16. Two immunosuppressive drug regimens after renal transplantation: low dosage of cyclosporine adjusted on the basis of high-performance liquid chromatography whole blood levels and prednisone.
    Uchida K; Orihara A; Yamada N; Tominaga Y; Kawai M; Tanaka Y; Morozumi K; Hayashi S; Satake M; Taira N
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):401-5. PubMed ID: 3279629
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal transplants maintained on low-dose cyclosporine and prednisolone.
    Rogerson ME; Neild GH; Rudge CJ; Wood SM; Cairns HS; Mansell MA; Thompson FD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):114-6. PubMed ID: 3291222
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of delayed cyclosporine administration in recipients of cadaveric renal allografts subjected to prolonged cold ischemia.
    Jordan ML; Shoskes D; Cardella CJ
    Transplant Proc; 1989 Apr; 21(2):3319-20. PubMed ID: 2652824
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and experimental studies with cyclosporine in renal transplantation.
    Kahan BD; van Buren CT; Flechner SM; Jarowenko M; Yasumura T; Rogers AJ; Yoshimura N; LeGrue S; Drath D; Kerman RH
    Surgery; 1985 Feb; 97(2):125-40. PubMed ID: 3881837
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients.
    Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1835-8. PubMed ID: 3547890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.